Form 4 for MCRB Seres Therapeutics, Inc.
Accepted 2023-05-01 00:00:00 ET · period of report 2023-04-27 · accession 0000899243-23-011944 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-01 | 2023-04-27 | MCRB | Arkowitz David | CFO | A - Grant | $0.00 | +42.5K | 166.6K | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-04-27 | A | A | 42,500 | $0.00 | 166,613 | D | — | — | (F2) Includes 11,121 shares of common stock acquired under the Issuer's employee stock purchase plan. |